Manal Abdelmalek, MD
Enriched profileDirector of Hepatology and Director, MASLD Clinical Research; Professor of Medicine, Mayo Clinic · Mayo Clinic
Manal Abdelmalek is Director of Hepatology and Director, MASLD Clinical Research; Professor of Medicine, Mayo Clinic at Mayo Clinic. OpenAlex indexes 359 publications with 45,830 citations (h-index 92); ClinicalTrials.gov lists 6 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 5% of Gastroenterology profiles in the findmyKOL directory. Clarivate lists Manal Abdelmalek as a Highly Cited Researcher (Clinical Medicine, 2024).
Data verified 14 Aug 2026
Overview
Updated 27 Aug 2026
Manal F. Abdelmalek, MD, is Director of Hepatology and Director, MASLD Clinical Research at Mayo Clinic (Rochester, MN). The public record shows 359 publications with 45,830 citations (h-index 92), centered on Liver Disease Diagnosis and Treatment, Liver Disease and Transplantation, Diet, Metabolism, and Disease. It also documents an investigator role on 6 registered clinical trials, industry payments reported by 15 companies, 3 NIH-funded awards (2006–2022).
- Most recent indexed publication: 2026 · Hepatology (Baltimore, Md.)
- Top research focus: Liver Disease Diagnosis and Treatment
- 6 registered trials on ClinicalTrials.gov
- Open Payments reporting from 15 companies
Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 16 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 187.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 27 Aug 2026
Listed as an investigator on 6 registered studies on ClinicalTrials.gov. The most recent:
- Statins for the Treatment of NASH
Sponsor: Mayo Clinic
- JKB-121 for the Treatment of Nonalcoholic Steatohepatitis
Sponsor: Manal Abdelmalek
Industry payments
Updated 27 Aug 2026
15 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Novo Nordisk IncProgram year202529 payments$75,737openpaymentsdata.cms.gov ↗
- Merck Sharp & Dohme LLCProgram year202514 payments$24,796openpaymentsdata.cms.gov ↗
- Boehringer Ingelheim International GmbHProgram year20257 payments
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
26.7%Rifamycin Antibacterial26.7%Xifaxan100%Part D<11 patientsCancer & immunology
24.4%Kinase inhibitor24.4%Ofev100%Part D<11 patientsHormonal (systemic)
24.4%l-Thyroxine24.4%Levothyroxine Sodium100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 27 Aug 2026
3 NIH research awards on record, funded 2006–2022 per NIH RePORTER. The latest:
- Prediction and Prevention of Hepatic Decompensation in Patients with Cirrhosis
Duke University
FY2022$189,022U01DK130177 - Prediction and Prevention of Hepatic Decompensation in Patients with Cirrhosis
Duke University
FY2021$382,543U01DK130177 - Impact of Fructose on Metabolism, Energy Homeostasis and MR biomarkers in NAFLD
Duke University
FY2014$314,000R01DK093568
Congress activity
Updated 27 Aug 2026
10 congress contributions (2018–2023) across AACE, ADA per OpenAlex. The most recent:
- 844-P: Lanifibranor Improves Markers of Cardiometabolic Health in Patients with NASH and Type 2 Diabetes, Correlated with Responses in Adiponectin Levels
ADA Scientific Sessions
ADA2023Co-authorPoster - 830-P: The Pan-PPAR Agonist Lanifibranor Improves Nonalcoholic Steatohepatitis (NASH) and Glycemic Control
ADA Scientific Sessions
ADA2022Co-authorPoster
Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.
Publications
Updated 27 Aug 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Betaine in the treatment of steatotic liver disease-Historical fad or a timeless treasure worth reviving?
Hepatology (Baltimore, Md.)
Article2026 - Current and emerging strategies for the prevention of hepatocellular carcinoma.
Nature reviews. Gastroenterology & hepatology
Review2025 - Impact of Weight Loss on Metabolic Dysfunction Associated Steatohepatitis and Hepatic Fibrosis.
Current diabetes reports
Review2025 - The role of glucagon-like peptide-1 receptor agonists in metabolic dysfunction-associated steatohepatitis.
Diabetes, obesity & metabolism
Review2024
Most-cited works
by citation count (OpenAlex)Network
Updated 27 Aug 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 27 Aug 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/manal-abdelmalek-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗ - Doximity
doximity.com/pub/manal-abdelmalek-md-e59cc3f0
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗ - LinkedIn
linkedin.com/in/manal-abdelmalek-8593073a
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com ↗
Mentions by others
where others cite or feature them- YouTube
youtube.com/watch
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →youtube.com ↗ - YouTube
youtube.com/watch
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →youtube.com ↗ - ResearchGate
ResearchGate profile: Manal Abdelmalek, Mayo Clinic - Rochester, Department of Gastroenterology and Hepatology, listed as Professor (Full)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →researchgate.net ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 27 Aug 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →dukehealth.org ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →dukehealth.org ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →dukehealth.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →dukehealth.org ↗
- Board Certified
Gastroenterology, American Board of Internal Medicine
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →connect.medicalnewstoday.com ↗ - Board Certified
Transplant Hepatology, American Board of Internal Medicine
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →dukehealth.org ↗
Editorial & leadership roles
journal and society appointments- Associate Editor
Hepatology (official journal of AASLD)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →onlinelibrary.wiley.com ↗ - Member
The Liver Forum
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →dukehealth.org ↗ - Steering Committee Member
NIH Liver Cirrhosis Network
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →dukehealth.org ↗
Highly Cited Researcher
Clarivate's annual list, by award category and year- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →clarivate.com ↗
Awards & honors
honors on the public record- Fellow
American College of Physicians (FACP)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →dukehealth.org ↗ - Fellow
American College of Gastroenterology (FACG)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →dukehealth.org ↗ - Fellow
American Association for the Study of Liver Diseases (FAASLD)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →aasld.org ↗
Secondary affiliations
appointments beyond the home institution- Former tenured Professor of Medicine
Division of Gastroenterology and Hepatology, and Director, NAFLD Clinical Research Program, Duke University (Durham, NC), prior institution before move to Mayo Clinic
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →medicine.duke.edu ↗
Media & interviews
press, podcasts and appearances- Guest
"Surfing the MASH Tsunami" podcast (SurfingNASH.com), episodes on FDA approval of semaglutide for non-cirrhotic MASH, September 2025
2025provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →surfingmash.com ↗ - provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →mashtag.org ↗
- Faculty
Second Annual Primary Care NAFLD/NASH Summit (Fatty Liver Alliance)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →fattyliver.ca ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
S Rajkumar, MD
Mayo Clinic
Bradley Boeve, MD
Mayo Clinic
Rick Nishimura, MD
Mayo Clinic
Victor Montori, MD
Mayo Clinic